KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation

SJ Chadban, C Ahn, DA Axelrod, BJ Foster… - …, 2020 - journals.lww.com
Abstract The 2020 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice
Guideline on the Evaluation and Management of Candidates for Kidney Transplantation is …

Post-transplant diabetes mellitus in patients with solid organ transplants

T Jenssen, A Hartmann - Nature Reviews Endocrinology, 2019 - nature.com
Solid organ transplantation (SOT) is a life-saving procedure and an established treatment for
patients with end-stage organ failure. However, transplantation is also accompanied by …

Practical recommendations for long-term management of modifiable risks in kidney and liver transplant recipients: a guidance report and clinical checklist by the …

JM Neuberger, WO Bechstein, DRJ Kuypers… - …, 2017 - journals.lww.com
Short-term patient and graft outcomes continue to improve after kidney and liver
transplantation, with 1-year survival rates over 80%; however, improving longer-term …

Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes

V Shivaswamy, B Boerner, J Larsen - Endocrine reviews, 2016 - academic.oup.com
Post-transplant diabetes mellitus (PTDM) is a frequent consequence of solid organ
transplantation. PTDM has been associated with greater mortality and increased infections …

[HTML][HTML] Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions

A Sharif, M Hecking, APJ De Vries, E Porrini… - American Journal of …, 2014 - Elsevier
A consensus meeting was held in Vienna on September 8–9, 2013, to discuss diagnostic
and therapeutic challenges surrounding development of diabetes mellitus after …

The many faces of calcineurin inhibitor toxicity—What the FK?

SS Farouk, JL Rein - Advances in Chronic Kidney Disease, 2020 - Elsevier
Calcineurin inhibitors (CNIs) are both the savior and Achilles' heel of kidney transplantation.
Although CNIs have significantly reduced rates of acute rejection, their numerous toxicities …

Management of post‐transplant diabetes: immunosuppression, early prevention, and novel antidiabetics

M Hecking, A Sharif, K Eller… - Transplant International, 2021 - Wiley Online Library
Post‐transplant diabetes mellitus (PTDM) shows a relationship with risk factors including
obesity and tacrolimus‐based immunosuppression, which decreases pancreatic insulin …

Cardiovascular morbidity and mortality after kidney transplantation

S Stoumpos, AG Jardine, PB Mark - Transplant International, 2015 - Wiley Online Library
Kidney transplantation is the optimal treatment for patients with end stage renal disease
(ESRD) who would otherwise require dialysis. Patients with ESRD are at dramatically …

Efficacy and safety of empagliflozin in renal transplant recipients with posttransplant diabetes mellitus

TAS Halden, KE Kvitne, K Midtvedt, L Rajakumar… - Diabetes …, 2019 - Am Diabetes Assoc
OBJECTIVE Sodium–glucose cotransporter 2 (SGLT2) inhibitors have lately become the
recommended treatment in patients with type 2 diabetes and high cardiovascular risk …

Empagliflozin in posttransplantation diabetes mellitus: a prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety

E Schwaiger, L Burghart, L Signorini… - American Journal of …, 2019 - Wiley Online Library
The safety and efficacy of sodium‐glucose cotransporter 2 inhibitors in posttransplantation
diabetes mellitus is unknown. We converted stable kidney transplant patients to 10 mg …